Brief Description
Algen Biotechnologies is building a next-generation, functional genomics-based platform for the discovery of novel therapeutics for cancers with high unmet need. Algen’s research group focuses on developing and applying novel functional genomics technologies to address scientific challenges in drug discovery. The company's biologists and data scientists are collaborating to deliver innovative, patient-centric medicines for the toughest-to-treat diseases.
The company was founded to commercialize technology developed at UC Berkeley while Algen Biotechnologies CEO Chun-Hao Hung was a postdoc in the lab of Jennifer Doudna, professor of biochemistry, biophysics and structural biology and Nobel Laureate in Chemistry.
Timeline
- 2018. Company founded
Inventors
Jennifer Doudna, Chun-Hao Huang, Spencer Knight, Nami Saghaei